Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial

Open Access

Peer-reviewed

Research Article

Jörg Täubel ,

* E-mail: j.taubel@richmondpharmacology.com

Affiliation Richmond Pharmacology Ltd, St George's University of London, Cranmer Terrace, London, United Kingdom
⨯
Georg Ferber,

Affiliation Statistik Georg Ferber GmbH, Cagliostrostrasse, Riehen, Switzerland
⨯
Sara Fernandes,

Affiliation Richmond Pharmacology Ltd, St George's University of London, Cranmer Terrace, London, United Kingdom
⨯
Ulrike Lorch,

Affiliation Richmond Pharmacology Ltd, St George's University of London, Cranmer Terrace, London, United Kingdom
⨯
Eva Santamaría,

Affiliation J. Uriach y Compañía, S.A., Avda. Camí Reial, Barcelona, Spain
⨯
Iñaki Izquierdo

Affiliation J. Uriach y Compañía, S.A., Avda. Camí Reial, Barcelona, Spain
⨯

Reader Comments (0)

Drug metabolism
Is the Subject Area "Drug metabolism" applicable to this article?

Thanks for your feedback.
Pharmacokinetics
Is the Subject Area "Pharmacokinetics" applicable to this article?

Thanks for your feedback.
Reaction time
Is the Subject Area "Reaction time" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Metabolites
Is the Subject Area "Metabolites" applicable to this article?

Thanks for your feedback.
Electrocardiography
Is the Subject Area "Electrocardiography" applicable to this article?

Thanks for your feedback.
Oral administration
Is the Subject Area "Oral administration" applicable to this article?

Thanks for your feedback.